Coloma Jason V Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$50,388.00

Insider Activity of Coloma Jason V

According to the SEC Form 4 filings, Coloma Jason V, being in a position of

  1. Chief Executive Officer at Maze Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 229645 shares for $6.19M,
    over all time since 2026-05-15, has bought 0 shares, and sold 229645 shares for $6.19M.

Biography of Coloma Jason V

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$6,186,76012100

Comparison of Insiders on Amount of Buys and Sells

2026-10-01SaleMaze Therapeutics, Inc.
MAZE
Chief Executive Officer
34,501
0.0632%
$27.02$932,260+11.44%
2026-09-03SaleMaze Therapeutics, Inc.
MAZE
Chief Executive Officer
11,411
0.0207%
$26.01$296,807+3.42%
2026-09-02SaleMaze Therapeutics, Inc.
MAZE
Chief Executive Officer
11,227
0.0201%
$26.47$297,148-0.22%
2026-09-01SaleMaze Therapeutics, Inc.
MAZE
Chief Executive Officer
34,501
0.0618%
$26.29$906,999+0.6%
2026-08-03SaleMaze Therapeutics, Inc.
MAZE
Chief Executive Officer
34,501
0.0626%
$26.73$922,315+0.4%
2026-07-01SaleMaze Therapeutics, Inc.
MAZE
Chief Executive Officer
34,501
0.0627%
$29.98$1.03M-7.15%
2026-06-23SaleMaze Therapeutics, Inc.
MAZE
Chief Executive Officer
23,865
0.0425%
$26.05$621,674+4.85%
2026-06-22SaleMaze Therapeutics, Inc.
MAZE
Chief Executive Officer
3,993
0.0073%
$26.00$103,821+8.27%
2026-06-01SaleMaze Therapeutics, Inc.
MAZE
Chief Executive Officer
6,643
0.0124%
$26.20$174,048+7.86%
2026-05-26SaleMaze Therapeutics, Inc.
MAZE
Chief Executive Officer
25,582
0.0462%
$26.02$665,516+3.68%
2026-05-22SaleMaze Therapeutics, Inc.
MAZE
Chief Executive Officer
6,982
0.0127%
$26.00$181,532+5.93%
2026-05-15SaleMaze Therapeutics, Inc.
MAZE
Chief Executive Officer
1,938
0.0036%
$26.00$50,388+6.51%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.